Reports

Industry Research Reports

Global Nitinol-based Interventional Device Market Research Report 2025

Global Nitinol-based Interventional Device Market Research Report 2025

Industry: Medical Devices & Consumables

Published Date: 2025-01-16

Pages: 91 Pages

Report ld: 3445457

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Nitinol-based Interventional Device Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

7.5%

marketSize

Market Size,2031

USD 41,550

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 26,920 million
Market Forecast in 2031(Value)
US$ 41,550 million
CAGR
7.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Nitinol-based Interventional Device was valued at US$ 25220 million in the year 2024 and is projected to reach a revised size of US$ 41550 million by 2031, growing at a CAGR of 7.5% during the forecast period.

Nitinol is a special metal that have the ability to restore their original shape after severe deformation. The nitinol medical devices include nitinol stents, nitinol guidewires, nitinol filters etc

The Nitinol-based Interventional Device market is driven by the growing demand for minimally invasive medical procedures and the unique properties of Nitinol alloy in interventional device design. Nitinol, a shape memory alloy, offers remarkable flexibility, shape retention, and biocompatibility, making it an ideal material for various interventional devices like stents, guidewires, and filters. The rise in chronic diseases, such as cardiovascular conditions and peripheral artery diseases, contributes to market growth as healthcare professionals seek advanced devices that ensure precise placement and effective treatment. Moreover, Nitinol"s ability to change shape with temperature variations aligns with improved device deployment and reduced patient discomfort. However, the market also faces challenges, including manufacturing complexities due to the unique properties of Nitinol and the need for rigorous testing to ensure device reliability. Additionally, addressing concerns related to long-term device performance and biocompatibility, and managing potential allergic reactions, can pose obstacles for manufacturers. To succeed, companies must focus on material advancements, precise device engineering, and addressing the challenges to provide safe and efficient Nitinol-based interventional devices that enhance patient outcomes and revolutionize minimally invasive medical procedures.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Nitinol-based Interventional Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nitinol-based Interventional Device.

The Nitinol-based Interventional Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nitinol-based Interventional Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nitinol-based Interventional Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Abbott

Edwards Lifesciences

Medtronic

Boston Scientific

TERUMO

BD

Stryker

Cook Medical

Cordis

B. Braun

Biotronik

MicroPort

JOTEC

Acandis

ELLA-CS

Segment by Type

Stents

Guidewires

Others

Segment by Application

Hospital

Clinic

Others

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Nitinol-based Interventional Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Nitinol-based Interventional Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report. 

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Nitinol-based Interventional Device Market Overview

1.1 Product Definition

1.2 Nitinol-based Interventional Device by Type

1.2.1 Global Nitinol-based Interventional Device Market Value Comparison by Type (2024 VS 2031)

1.2.2 Stents

1.2.3 Guidewires

1.2.4 Others

1.3 Nitinol-based Interventional Device by Application

1.3.1 Global Nitinol-based Interventional Device Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Nitinol-based Interventional Device Market Size Estimates and Forecasts

1.4.1 Global Nitinol-based Interventional Device Revenue 2020-2031

1.4.2 Global Nitinol-based Interventional Device Sales 2020-2031

1.4.3 Global Nitinol-based Interventional Device Market Average Price (2020-2031)

1.5 Assumptions and Limitations

muLu

2 Nitinol-based Interventional Device Market Competition by Manufacturers

2.1 Global Nitinol-based Interventional Device Sales Market Share by Manufacturers (2020-2025)

2.2 Global Nitinol-based Interventional Device Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Nitinol-based Interventional Device Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Nitinol-based Interventional Device, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Nitinol-based Interventional Device, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Nitinol-based Interventional Device, Product Type & Application

2.7 Global Key Manufacturers of Nitinol-based Interventional Device, Date of Enter into This Industry

2.8 Global Nitinol-based Interventional Device Market Competitive Situation and Trends

2.8.1 Global Nitinol-based Interventional Device Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Nitinol-based Interventional Device Players Market Share by Revenue

2.8.3 Global Nitinol-based Interventional Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

muLu

3 Global Nitinol-based Interventional Device Market Scenario by Region

3.1 Global Nitinol-based Interventional Device Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Nitinol-based Interventional Device Sales by Region: 2020-2031

3.2.1 Global Nitinol-based Interventional Device Sales by Region: 2020-2025

3.2.2 Global Nitinol-based Interventional Device Sales by Region: 2026-2031

3.3 Global Nitinol-based Interventional Device Revenue by Region: 2020-2031

3.3.1 Global Nitinol-based Interventional Device Revenue by Region: 2020-2025

3.3.2 Global Nitinol-based Interventional Device Revenue by Region: 2026-2031

3.4 North America Nitinol-based Interventional Device Market Facts & Figures by Country

3.4.1 North America Nitinol-based Interventional Device Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Nitinol-based Interventional Device Sales by Country (2020-2031)

3.4.3 North America Nitinol-based Interventional Device Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Nitinol-based Interventional Device Market Facts & Figures by Country

3.5.1 Europe Nitinol-based Interventional Device Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Nitinol-based Interventional Device Sales by Country (2020-2031)

3.5.3 Europe Nitinol-based Interventional Device Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Nitinol-based Interventional Device Market Facts & Figures by Region

3.6.1 Asia Pacific Nitinol-based Interventional Device Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Nitinol-based Interventional Device Sales by Region (2020-2031)

3.6.3 Asia Pacific Nitinol-based Interventional Device Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Nitinol-based Interventional Device Market Facts & Figures by Country

3.7.1 Latin America Nitinol-based Interventional Device Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Nitinol-based Interventional Device Sales by Country (2020-2031)

3.7.3 Latin America Nitinol-based Interventional Device Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Nitinol-based Interventional Device Market Facts & Figures by Country

3.8.1 Middle East and Africa Nitinol-based Interventional Device Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Nitinol-based Interventional Device Sales by Country (2020-2031)

3.8.3 Middle East and Africa Nitinol-based Interventional Device Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

muLu

4 Segment by Type

4.1 Global Nitinol-based Interventional Device Sales by Type (2020-2031)

4.1.1 Global Nitinol-based Interventional Device Sales by Type (2020-2025)

4.1.2 Global Nitinol-based Interventional Device Sales by Type (2026-2031)

4.1.3 Global Nitinol-based Interventional Device Sales Market Share by Type (2020-2031)

4.2 Global Nitinol-based Interventional Device Revenue by Type (2020-2031)

4.2.1 Global Nitinol-based Interventional Device Revenue by Type (2020-2025)

4.2.2 Global Nitinol-based Interventional Device Revenue by Type (2026-2031)

4.2.3 Global Nitinol-based Interventional Device Revenue Market Share by Type (2020-2031)

4.3 Global Nitinol-based Interventional Device Price by Type (2020-2031)

muLu

5 Segment by Application

5.1 Global Nitinol-based Interventional Device Sales by Application (2020-2031)

5.1.1 Global Nitinol-based Interventional Device Sales by Application (2020-2025)

5.1.2 Global Nitinol-based Interventional Device Sales by Application (2026-2031)

5.1.3 Global Nitinol-based Interventional Device Sales Market Share by Application (2020-2031)

5.2 Global Nitinol-based Interventional Device Revenue by Application (2020-2031)

5.2.1 Global Nitinol-based Interventional Device Revenue by Application (2020-2025)

5.2.2 Global Nitinol-based Interventional Device Revenue by Application (2026-2031)

5.2.3 Global Nitinol-based Interventional Device Revenue Market Share by Application (2020-2031)

5.3 Global Nitinol-based Interventional Device Price by Application (2020-2031)

muLu

6 Key Companies Profiled

6.1 Abbott

6.1.1 Abbott Company Information

6.1.2 Abbott Description and Business Overview

6.1.3 Abbott Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Abbott Nitinol-based Interventional Device Product Portfolio

6.1.5 Abbott Recent Developments/Updates

6.2 Edwards Lifesciences

6.2.1 Edwards Lifesciences Company Information

6.2.2 Edwards Lifesciences Description and Business Overview

6.2.3 Edwards Lifesciences Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Edwards Lifesciences Nitinol-based Interventional Device Product Portfolio

6.2.5 Edwards Lifesciences Recent Developments/Updates

6.3 Medtronic

6.3.1 Medtronic Company Information

6.3.2 Medtronic Description and Business Overview

6.3.3 Medtronic Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Medtronic Nitinol-based Interventional Device Product Portfolio

6.3.5 Medtronic Recent Developments/Updates

6.4 Boston Scientific

6.4.1 Boston Scientific Company Information

6.4.2 Boston Scientific Description and Business Overview

6.4.3 Boston Scientific Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Boston Scientific Nitinol-based Interventional Device Product Portfolio

6.4.5 Boston Scientific Recent Developments/Updates

6.5 TERUMO

6.5.1 TERUMO Company Information

6.5.2 TERUMO Description and Business Overview

6.5.3 TERUMO Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.5.4 TERUMO Nitinol-based Interventional Device Product Portfolio

6.5.5 TERUMO Recent Developments/Updates

6.6 BD

6.6.1 BD Company Information

6.6.2 BD Description and Business Overview

6.6.3 BD Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.6.4 BD Nitinol-based Interventional Device Product Portfolio

6.6.5 BD Recent Developments/Updates

6.7 Stryker

6.7.1 Stryker Company Information

6.7.2 Stryker Description and Business Overview

6.7.3 Stryker Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Stryker Nitinol-based Interventional Device Product Portfolio

6.7.5 Stryker Recent Developments/Updates

6.8 Cook Medical

6.8.1 Cook Medical Company Information

6.8.2 Cook Medical Description and Business Overview

6.8.3 Cook Medical Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Cook Medical Nitinol-based Interventional Device Product Portfolio

6.8.5 Cook Medical Recent Developments/Updates

6.9 Cordis

6.9.1 Cordis Company Information

6.9.2 Cordis Description and Business Overview

6.9.3 Cordis Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Cordis Nitinol-based Interventional Device Product Portfolio

6.9.5 Cordis Recent Developments/Updates

6.10 B. Braun

6.10.1 B. Braun Company Information

6.10.2 B. Braun Description and Business Overview

6.10.3 B. Braun Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.10.4 B. Braun Nitinol-based Interventional Device Product Portfolio

6.10.5 B. Braun Recent Developments/Updates

6.11 Biotronik

6.11.1 Biotronik Company Information

6.11.2 Biotronik Description and Business Overview

6.11.3 Biotronik Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Biotronik Nitinol-based Interventional Device Product Portfolio

6.11.5 Biotronik Recent Developments/Updates

6.12 MicroPort

6.12.1 MicroPort Company Information

6.12.2 MicroPort Description and Business Overview

6.12.3 MicroPort Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.12.4 MicroPort Nitinol-based Interventional Device Product Portfolio

6.12.5 MicroPort Recent Developments/Updates

6.13 JOTEC

6.13.1 JOTEC Company Information

6.13.2 JOTEC Description and Business Overview

6.13.3 JOTEC Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.13.4 JOTEC Nitinol-based Interventional Device Product Portfolio

6.13.5 JOTEC Recent Developments/Updates

6.14 Acandis

6.14.1 Acandis Company Information

6.14.2 Acandis Description and Business Overview

6.14.3 Acandis Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Acandis Nitinol-based Interventional Device Product Portfolio

6.14.5 Acandis Recent Developments/Updates

6.15 ELLA-CS

6.15.1 ELLA-CS Company Information

6.15.2 ELLA-CS Description and Business Overview

6.15.3 ELLA-CS Nitinol-based Interventional Device Sales, Revenue and Gross Margin (2020-2025)

6.15.4 ELLA-CS Nitinol-based Interventional Device Product Portfolio

6.15.5 ELLA-CS Recent Developments/Updates

muLu

7 Industry Chain and Sales Channels Analysis

7.1 Nitinol-based Interventional Device Industry Chain Analysis

7.2 Nitinol-based Interventional Device Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Nitinol-based Interventional Device Production Mode & Process Analysis

7.4 Nitinol-based Interventional Device Sales and Marketing

7.4.1 Nitinol-based Interventional Device Sales Channels

7.4.2 Nitinol-based Interventional Device Distributors

7.5 Nitinol-based Interventional Device Customer Analysis

muLu

8 Nitinol-based Interventional Device Market Dynamics

8.1 Nitinol-based Interventional Device Industry Trends

8.2 Nitinol-based Interventional Device Market Drivers

8.3 Nitinol-based Interventional Device Market Challenges

8.4 Nitinol-based Interventional Device Market Restraints

muLu

9 Research Findings and Conclusion

muLu

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Nitinol-based Interventional Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Nitinol-based Interventional Device Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Nitinol-based Interventional Device Market Competitive Situation by Manufacturers in 2024
Table 4. Global Nitinol-based Interventional Device Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Nitinol-based Interventional Device Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Nitinol-based Interventional Device Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Nitinol-based Interventional Device Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Nitinol-based Interventional Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Nitinol-based Interventional Device, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nitinol-based Interventional Device, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nitinol-based Interventional Device, Product Type & Application
Table 12. Global Key Manufacturers of Nitinol-based Interventional Device, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nitinol-based Interventional Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nitinol-based Interventional Device as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nitinol-based Interventional Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Nitinol-based Interventional Device Sales by Region (2020-2025) & (K Units)
Table 18. Global Nitinol-based Interventional Device Sales Market Share by Region (2020-2025)
Table 19. Global Nitinol-based Interventional Device Sales by Region (2026-2031) & (K Units)
Table 20. Global Nitinol-based Interventional Device Sales Market Share by Region (2026-2031)
Table 21. Global Nitinol-based Interventional Device Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Nitinol-based Interventional Device Revenue Market Share by Region (2020-2025)
Table 23. Global Nitinol-based Interventional Device Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Nitinol-based Interventional Device Revenue Market Share by Region (2026-2031)
Table 25. North America Nitinol-based Interventional Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Nitinol-based Interventional Device Sales by Country (2020-2025) & (K Units)
Table 27. North America Nitinol-based Interventional Device Sales by Country (2026-2031) & (K Units)
Table 28. North America Nitinol-based Interventional Device Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Nitinol-based Interventional Device Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Nitinol-based Interventional Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Nitinol-based Interventional Device Sales by Country (2020-2025) & (K Units)
Table 32. Europe Nitinol-based Interventional Device Sales by Country (2026-2031) & (K Units)
Table 33. Europe Nitinol-based Interventional Device Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Nitinol-based Interventional Device Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Nitinol-based Interventional Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Nitinol-based Interventional Device Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Nitinol-based Interventional Device Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Nitinol-based Interventional Device Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Nitinol-based Interventional Device Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nitinol-based Interventional Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Nitinol-based Interventional Device Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Nitinol-based Interventional Device Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Nitinol-based Interventional Device Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nitinol-based Interventional Device Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Nitinol-based Interventional Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Nitinol-based Interventional Device Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Nitinol-based Interventional Device Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Nitinol-based Interventional Device Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Nitinol-based Interventional Device Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Nitinol-based Interventional Device Sales (K Units) by Type (2020-2025)
Table 51. Global Nitinol-based Interventional Device Sales (K Units) by Type (2026-2031)
Table 52. Global Nitinol-based Interventional Device Sales Market Share by Type (2020-2025)
Table 53. Global Nitinol-based Interventional Device Sales Market Share by Type (2026-2031)
Table 54. Global Nitinol-based Interventional Device Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Nitinol-based Interventional Device Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Nitinol-based Interventional Device Revenue Market Share by Type (2020-2025)
Table 57. Global Nitinol-based Interventional Device Revenue Market Share by Type (2026-2031)
Table 58. Global Nitinol-based Interventional Device Price (US$/Unit) by Type (2020-2025)
Table 59. Global Nitinol-based Interventional Device Price (US$/Unit) by Type (2026-2031)
Table 60. Global Nitinol-based Interventional Device Sales (K Units) by Application (2020-2025)
Table 61. Global Nitinol-based Interventional Device Sales (K Units) by Application (2026-2031)
Table 62. Global Nitinol-based Interventional Device Sales Market Share by Application (2020-2025)
Table 63. Global Nitinol-based Interventional Device Sales Market Share by Application (2026-2031)
Table 64. Global Nitinol-based Interventional Device Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Nitinol-based Interventional Device Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Nitinol-based Interventional Device Revenue Market Share by Application (2020-2025)
Table 67. Global Nitinol-based Interventional Device Revenue Market Share by Application (2026-2031)
Table 68. Global Nitinol-based Interventional Device Price (US$/Unit) by Application (2020-2025)
Table 69. Global Nitinol-based Interventional Device Price (US$/Unit) by Application (2026-2031)
Table 70. Abbott Company Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Abbott Nitinol-based Interventional Device Product
Table 74. Abbott Recent Developments/Updates
Table 75. Edwards Lifesciences Company Information
Table 76. Edwards Lifesciences Description and Business Overview
Table 77. Edwards Lifesciences Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Edwards Lifesciences Nitinol-based Interventional Device Product
Table 79. Edwards Lifesciences Recent Developments/Updates
Table 80. Medtronic Company Information
Table 81. Medtronic Description and Business Overview
Table 82. Medtronic Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Medtronic Nitinol-based Interventional Device Product
Table 84. Medtronic Recent Developments/Updates
Table 85. Boston Scientific Company Information
Table 86. Boston Scientific Description and Business Overview
Table 87. Boston Scientific Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Boston Scientific Nitinol-based Interventional Device Product
Table 89. Boston Scientific Recent Developments/Updates
Table 90. TERUMO Company Information
Table 91. TERUMO Description and Business Overview
Table 92. TERUMO Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. TERUMO Nitinol-based Interventional Device Product
Table 94. TERUMO Recent Developments/Updates
Table 95. BD Company Information
Table 96. BD Description and Business Overview
Table 97. BD Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. BD Nitinol-based Interventional Device Product
Table 99. BD Recent Developments/Updates
Table 100. Stryker Company Information
Table 101. Stryker Description and Business Overview
Table 102. Stryker Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Stryker Nitinol-based Interventional Device Product
Table 104. Stryker Recent Developments/Updates
Table 105. Cook Medical Company Information
Table 106. Cook Medical Description and Business Overview
Table 107. Cook Medical Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Cook Medical Nitinol-based Interventional Device Product
Table 109. Cook Medical Recent Developments/Updates
Table 110. Cordis Company Information
Table 111. Cordis Description and Business Overview
Table 112. Cordis Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Cordis Nitinol-based Interventional Device Product
Table 114. Cordis Recent Developments/Updates
Table 115. B. Braun Company Information
Table 116. B. Braun Description and Business Overview
Table 117. B. Braun Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. B. Braun Nitinol-based Interventional Device Product
Table 119. B. Braun Recent Developments/Updates
Table 120. Biotronik Company Information
Table 121. Biotronik Description and Business Overview
Table 122. Biotronik Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Biotronik Nitinol-based Interventional Device Product
Table 124. Biotronik Recent Developments/Updates
Table 125. MicroPort Company Information
Table 126. MicroPort Description and Business Overview
Table 127. MicroPort Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. MicroPort Nitinol-based Interventional Device Product
Table 129. MicroPort Recent Developments/Updates
Table 130. JOTEC Company Information
Table 131. JOTEC Description and Business Overview
Table 132. JOTEC Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. JOTEC Nitinol-based Interventional Device Product
Table 134. JOTEC Recent Developments/Updates
Table 135. Acandis Company Information
Table 136. Acandis Description and Business Overview
Table 137. Acandis Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Acandis Nitinol-based Interventional Device Product
Table 139. Acandis Recent Developments/Updates
Table 140. ELLA-CS Company Information
Table 141. ELLA-CS Description and Business Overview
Table 142. ELLA-CS Nitinol-based Interventional Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. ELLA-CS Nitinol-based Interventional Device Product
Table 144. ELLA-CS Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Nitinol-based Interventional Device Distributors List
Table 148. Nitinol-based Interventional Device Customers List
Table 149. Nitinol-based Interventional Device Market Trends
Table 150. Nitinol-based Interventional Device Market Drivers
Table 151. Nitinol-based Interventional Device Market Challenges
Table 152. Nitinol-based Interventional Device Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
muLu

List of Figures

Figure 1. Product Picture of Nitinol-based Interventional Device
Figure 2. Global Nitinol-based Interventional Device Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nitinol-based Interventional Device Market Share by Type: 2024 & 2031
Figure 4. Stents Product Picture
Figure 5. Guidewires Product Picture
Figure 6. Others Product Picture
Figure 7. Global Nitinol-based Interventional Device Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Nitinol-based Interventional Device Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Nitinol-based Interventional Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Nitinol-based Interventional Device Market Size (2020-2031) & (US$ Million)
Figure 14. Global Nitinol-based Interventional Device Sales (2020-2031) & (K Units)
Figure 15. Global Nitinol-based Interventional Device Average Price (US$/Unit) & (2020-2031)
Figure 16. Nitinol-based Interventional Device Report Years Considered
Figure 17. Nitinol-based Interventional Device Sales Share by Manufacturers in 2024
Figure 18. Global Nitinol-based Interventional Device Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Nitinol-based Interventional Device Players: Market Share by Revenue in Nitinol-based Interventional Device in 2024
Figure 20. Nitinol-based Interventional Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Nitinol-based Interventional Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Nitinol-based Interventional Device Sales Market Share by Country (2020-2031)
Figure 23. North America Nitinol-based Interventional Device Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Nitinol-based Interventional Device Sales Market Share by Country (2020-2031)
Figure 27. Europe Nitinol-based Interventional Device Revenue Market Share by Country (2020-2031)
Figure 28. Germany Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Nitinol-based Interventional Device Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Nitinol-based Interventional Device Revenue Market Share by Region (2020-2031)
Figure 35. China Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Nitinol-based Interventional Device Sales Market Share by Country (2020-2031)
Figure 46. Latin America Nitinol-based Interventional Device Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Nitinol-based Interventional Device Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Nitinol-based Interventional Device Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Nitinol-based Interventional Device Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Nitinol-based Interventional Device by Type (2020-2031)
Figure 56. Global Revenue Market Share of Nitinol-based Interventional Device by Type (2020-2031)
Figure 57. Global Nitinol-based Interventional Device Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Nitinol-based Interventional Device by Application (2020-2031)
Figure 59. Global Revenue Market Share of Nitinol-based Interventional Device by Application (2020-2031)
Figure 60. Global Nitinol-based Interventional Device Price (US$/Unit) by Application (2020-2031)
Figure 61. Nitinol-based Interventional Device Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Nitinol-based Interventional Device in 2025?zhanKai
The global market size of Nitinol-based Interventional Device in 2025 was 26920 Million USD.
Which companies rank high in the global Nitinol-based Interventional Device market?shouQi
Which region is expected to have the highest market share?shouQi
What is the annual compound growth rate of the global Nitinol-based Interventional Device market size from 2025 to 2031?shouQi
What was the global market size of Nitinol-based Interventional Device in 2031?shouQi
den_biaoTiZhungShi

Related Reports

Global Nitinol-based Interventional Device Market Research Report 2025

Industry: Medical Devices & Consumables

Published Date: 2025-01-16

Pages: 91 Pages

Report ld: 3445457

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

REPORT SCOPE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now